Smith+Nephew is a leading portfolio medical technology company.
Since 1856, when our founder T.J. Smith developed a new method for refining cod liver oil, and in World War One when his nephew led the supply of wound care products, to the present day, Smith & Nephew continues to pioneer health solutions.
Through our market leadership positions in Sports Medicine, Orthopaedic Reconstruction and Advanced Wound Management, our 17,500+ employees continue to improve outcomes and expand access.
We are a constituent of the UK’s FTSE100 and our shares are traded on London Stock Exchange and through American Depository Receipts on the New York Stock Exchange (LSE: SN,NYSE:SNN).
Please note: not all products referred to may be approved for use or available in all markets.
Contact Redox to learn how your organization can integrate any of the healthcare products listed here today.